Infinity Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Infinity Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 10.90 million shares as of 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2023-03-28
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 10.90M shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 9.08M shares.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 8.08M shares.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 7.79M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2022-12-31 | 10.90M shares 10-K · filed 2023-03-28 |
| 2021-12-31 | 9.08M shares 10-K · filed 2022-03-29 |
| 2020-12-31 | 8.08M shares 10-K · filed 2021-03-16 |
| 2019-12-31 | 7.79M shares 10-K · filed 2020-03-03 |
| 2018-12-31 | 6.40M shares 10-K · filed 2019-03-14 |
| 2017-12-31 | 3.03M shares 10-K · filed 2018-03-15 |
| 2016-12-31 | 4.80M shares 10-K · filed 2017-03-14 |
| 2015-12-31 | 5.65M shares 10-K · filed 2016-02-23 |
| 2014-12-31 | 4.70M shares 10-K · filed 2015-02-24 |
| 2013-12-31 | 4.11M shares 10-K · filed 2014-02-25 |
| 2012-12-31 | 3.48M shares 10-K · filed 2013-03-05 |